PharmaBoardroom

Regulatory, Pricing and Reimbursement Overview: Peru

An intro to the regulatory, pricing and reimbursement scenario for pharmaceuticals in Peru. Prepared in association with Osterling Abogados, a leading…

French Government Signs Strategic Contract for Healthcare and…

On February 4 in Paris, Minister of Health and Solidarity Agnès Buzyn, Minister of Higher Education, Research and Innovation Frédérique Vidal,…

Frank Margain – President, Paris Region Entreprises, France

Frank Margain, chairman of Paris Region Entreprises, the ‘Invest in Paris Region’ promotion agency, discusses the importance of the life sciences…

Adlane Soudani – General Manager, Ipsen Algeria

Adlane Soudani, general manager of Ipsen’s Algerian affiliate, lifts the lid on Ipsen’s ambitions for the local market, and the company’s…

How Beneficial Is The Recent Price Control Exemption For…

Anay Shukla leads the pharmaceutical, life sciences, med-tech and healthcare practice at Nishith Desai Associates, a leading Indian law firm. In this…

Emmanuelle Quilès – CEO, Janssen France

Emmanuelle Quilès, CEO of Janssen France, speaks about how she joined the American multinational with the ambition to bring digitalization and…

Malaysia’s Unexpected Health Reform Program

After 61 years of single-party rule, the May 2018 electoral victory of the populist Pakatan Harapan (PH) coalition sent shockwaves through the…

Cannabinoid Drugs, Medicinal Cannabis and Opioid Drugs: Ecuador

An intro to the legal situation for medical cannabis, cannabinoid drugs and opioids in Ecuador. Prepared in association with Corral Rosales, a leading…

India’s Drug Regulatory Reforms: Building Trust

Dilip Shah, the Secretary-General of the Indian Pharmaceutical Alliance advocates for a stronger and more empowered regulator in India if the country…

Jack Wang – Founder & CEO, Biomobie, China

Jack Wang, founder and CEO of Biomobie, shares the inspirational story behind the establishment of the company, the regenerative principle driving the…

4+7: China’s New Volume-Based Purchasing Policy

In late 2018 China adopted a novel procurement scheme with the aim of dramatically cutting the amount being paid for generic drugs. The policy’s…

Egyptian Pharma Market Snapshot

The Egyptian pharma market grew at a compound annual growth rate (CAGR) of 17 percent between 2011 and 2017 to reach a total market valuation of EGP…

Tagged with EG